	Glioblastoma as a neuro-immune network disorder: rethinking the tumor microenvironment, neural circuit integration, and therapeutic resistance. Oncol Rev Lo T, Bunjaj A, Turnbull JP, Desai S, Alsalahi A, Heitkotter H, Griepp DW, Richards BF. PMID: 42577360 [PubMed - as supplied by publisher]
	Exploratory genomic stratification of benefit from first-line immunotherapy-based combination in advanced biliary tract cancer: a biomarker analysis of a randomized phase 2 trial. Front Immunol He Y, Ruan Z, Xu X, Han Y, Yan J, Ni J, Xu Q, Ying J, Zhou S. PMID: 42577326 [PubMed - as supplied by publisher]
	Breast Cancer Risk Factors Analysis in Middle-Aged Women: Evidence From a Cross-Sectional Epidemiological Study. Health Sci Rep Ansari H, Yadollahi S, Allahyari S, Hajigholami A. PMID: 42577310 [PubMed - as supplied by publisher]
	Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer. Front Immunol Kong X, Su Y, Zheng H, Feng Z, Huang J, Zhang L, Li L. PMID: 42577301 [PubMed - as supplied by publisher]
	CT-derived topological intratumoral heterogeneity predicts major pathological response to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer: a two-center study. Front Immunol Zhou Y, Hong T, Qi H, Zhao J, Wu Z, Du J, Liu L, Zou F. PMID: 42577271 [PubMed - in process]
	A full-cycle integrated management model for esophageal cancer in county health systems: effects on care processes, clinical outcomes, quality of life, and cost-utility. Front Oncol Xiao J, Ye L, Zhou J, Li M, Sang Y, Huang D, Lin Q, Chen W. PMID: 42577252 [PubMed - in process]
	Factors Associated with Postoperative Skeletal Muscle Loss during Hospitalization in Patients with Non-Small Cell Lung Cancer Undergoing Lobectomy: An Exploratory Retrospective Cohort Study. JMA J Kido T, Shirado K, Kawamitsu K, Okuno S, Okamoto R, Yasuda M. PMID: 42577243 [PubMed - in process]
	Association of dynamic platelet-to-lymphocyte ratio trajectories using group-based trajectory modeling with short-term outcomes and survival in patients undergoing laparoscopic radical resection for rectal cancer: a retrospective study. Front Oncol Lin B, Sun S, Zhang H, Lin C, Chi Y. PMID: 42577208 [PubMed - in process]
	A combined intervention of emotional freedom techniques and psychological nursing for reducing anticipatory grief in breast cancer patients undergoing chemotherapy: a retrospective cohort study. Front Public Health Zhao L, Lv M. PMID: 42577200 [PubMed - in process]
	An integrative analysis of UFMylation-related genes reveals a prognostic signature and identifies GDF7 as a novel therapeutic target in gastric cancer. Front Oncol Chen G, Gao X, Dai L, Deng S, Wang H, Huang X, Feng Y. PMID: 42577178 [PubMed - in process]
	Multimodal AI fusion: integrating MRI with PET/CT, histopathology, and liquid biopsy for bone tumor diagnosis. Front Oncol Li G, Lin Y, Wang X. PMID: 42577177 [PubMed - in process]
	Case Report: Phosphaturic mesenchymal tumor of the scapula without calcification: a potential diagnostic pitfall. Front Oncol Chen Y, Huang C, He X, Zhan L, Long L, Gu R, Guo D. PMID: 42577120 [PubMed - in process]
	Effects of self-management interventions on self-care ability and quality of life in patients with urinary ostomy after bladder cancer: a systematic review and meta-analysis. Front Oncol Tian J, Li L, Xu L, Liu L. PMID: 42577118 [PubMed - in process]
	A four-miRNA serum panel as a diagnostic biomarker for prostate cancer: an exploratory and validation study. Front Oncol Yang Z, Lai Z, Xie J, Chen S, Ge Z, Lai Y, Li H. PMID: 42577108 [PubMed - in process]
	Clinically detected hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive breast cancer patients receiving systemic therapy without antiviral prophylaxis: a two-centre descriptive cohort and nested case study. Front Oncol Yapar Toros G, Çeken S, Ocak Duran A, Ate. PMID: 42577092 [PubMed - in process]
	Triplet Therapy (Androgen Deprivation Therapy + Darolutamide + Biweekly Docetaxel) for High-risk Metastatic Castration-sensitive Prostate Cancer (TRIC Study): A Study Protocol for Open-labelled Single-Arm Phase II Clinical Trial. JMA J Iwamoto H, Hori T, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Yaegashi H, Nohara T, Shigehara K, Izumi K, Mizokami A. PMID: 42577021 [PubMed]
	Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy. JMA J Minato A, Sugita Y, Mizushima Y, Watanabe S, Matsukawa T, Jojima K, Kimuro R, Higashijima K, Nagata Y, Tomisaki I, Kashiwagi E. PMID: 42577015 [PubMed]
	Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome: only pertinent at diagnosis? Res Pract Thromb Haemost Lemarié F, Picard J, Galinat H, Jaouen S, Pan-Petesch B, Nicol C, Herbreteau L, Civi L, Rio L, Lambert WC, Olivier V, Lippert É, Ianotto JC. PMID: 42576955 [PubMed - indexed for MEDLINE]
	Editorial Comment to Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy. JMA J Miyakawa J. PMID: 42576949 [PubMed]
	Leveraging endogenous proteins to improve cancer nanomedicine delivery. Nanoscale Xu Z, Jolly KJ, Zhang F. PMID: 42576815 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1962697

Page 1 of 98135



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy